GLAUKOS CorpGKOSEarnings & Financial Report
NYSE · Health Care · Surgical & Medical Instruments & Apparatus
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 16.20% | 7.9M | — | 2024-01-22 |
| FMR LLC | 12.06% | 5.9M | ▲ +1.83pp | 2024-02-09 |
| The Vanguard Group | 10.73% | 5.2M | — | 2024-02-13 |
| Thomas W. Burns | 5.08% | 2.6M | — | 2024-02-13 |
| NOS. OF ABOVE PERSONS | 2.97% | 1.6M | ▼ -2.56pp | 2024-11-14 |
| Wellington Management Group LLP | 2.75% | 1.3M | — | 2024-01-10 |
Insider Transactions
Net 90d: −$2.60M · buys $0 / sells $2.60MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-10 | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Sell (open market) | 1.2K | $116.72 | $144.4K |
| 2026-04-10 | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Sell (open market) | 210 | $117.45 | $24.7K |
| 2026-04-10 | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Sell (open market) | 614 | $119.35 | $73.3K |
| 2026-04-10 | Tomas Navratil | CHIEF DEVELOPMENT OFFICER | Sell (open market) | 32 | $120.23 | $3.8K |
| 2026-04-01 | Burns Thomas William | CHAIRMAN & CEO | Gift | 180.3K | $0.00 | $0 |
| 2026-04-01 | Burns Thomas William | CHAIRMAN & CEO | Gift | 180.3K | $0.00 | $0 |
| 2026-03-25 | Burns Thomas William | CHAIRMAN & CEO | Grant | 9.4K | $0.00 | $0 |
| 2026-03-25 | Burns Thomas William | CHAIRMAN & CEO | Grant | 14.2K | $0.00 | $0 |
| 2026-03-25 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Sell (open market) | 2.5K | $106.46 | $267.3K |
| 2026-03-25 | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | Grant | 3.3K | $0.00 | $0 |
1–10 of 31
Page 1 / 4